Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs

Summary

The bill would make it illegal for drug makers, health insurers, pharmacy benefit managers and other payors to block or limit the purchase, delivery, or reimbursement of drugs obtained through the federal 340B program. It applies to any pharmacy that contracts with a 340B entity and to the insurers that pay for those drugs, treating discriminatory actions as unfair trade practices subject to state penalties. The measure aims to protect low‑cost drug access for safety‑net providers.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share